Anti-Human CD8 – Purified in vivo GOLD™ Functional Grade
Anti-Human CD8 – Purified in vivo GOLD™ Functional Grade
Product No.: C366
Clone UCHT-4 Target CD8 Formats AvailableView All Product Type Monoclonal Antibody Isotype Mouse IgG2a Applications FA , FC , in vivo , WB |
Antibody DetailsProduct DetailsReactive Species Human Host Species Mouse Recommended Isotype Controls Recommended Isotype Controls Recommended Dilution Buffer Immunogen Thymocytes and Sézary T cells Product Concentration ≥ 5.0 mg/ml Endotoxin Level < 1.0 EU/mg as determined by the LAL method Purity ≥95% monomer by analytical SEC ⋅ >95% by SDS Page Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day 2-8°C RRIDAB_2829678 Applications and Recommended Usage? Quality Tested by Leinco FC The suggested concentration for this UCHT-4 antibody for staining cells in flow cytometry is ≤ 1.0 μg per 106 cells in a volume of 100 μl or 100μl of whole blood. Titration of the reagent is recommended for optimal performance for each application. WB The suggested concentration for this UCHT-4 antibody for use in western blotting is 1-10 μg/ml. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Clone UCHT-4 recognizes human CD8. Background CD8 is made up of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8 is part of the Ig superfamily that expresses primarily as CD8a homodimers. CD8a is a 32-34 kD type I glycoprotein that can also form heterodimers with CD8b. CD8 is an antigen co-receptor on T cells that mediates efficient cell to cell interactions within the immune system. CD8 coupled with the T cell receptor on the T lymphocyte recognizes an antigen displayed by an antigen presenting cell (APC) in the context of class I MHC molecules. The CD8 co-receptor also plays a role in T cell signaling by interacting with Lck (lymphocyte-specific protein tyrosine kinase) which leads to the activation of transcription factors that affect the expression of certain genes. Antigen Distribution CD8 is expressed on blood lymphocytes, a subset of NK cells, and thymocytes. Persons with HIV exhibit increased levels of CD8+ lymphocytes. Ligand/Receptor MHC Class I molecules PubMed NCBI Gene Bank ID UniProt.org Research Area Immunology Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Clone UCHT-4 is a monoclonal antibody directed against human CD8 and is mainly used in immunology research, including in vivo mouse studies, for applications involving T-cell identification, depletion, and functional modulation. In in vivo mouse experiments, UCHT-4 is typically employed in the following ways:
Since UCHT-4 is specific for human CD8, it is mainly relevant in mouse models that possess a humanized immune system (for example, after engraftment with human hematopoietic stem cells or PBMCs), not in wild-type mice. Supporting context:
There is no evidence from the provided search results suggesting that UCHT-4 cross-reacts with murine CD8, so its use is focused solely on humanized models. If you require experimental protocol details (such as dosing, administration routes, or in vivo efficacy data), these specifics are not present in the retrieved documents and would need to be sourced from primary literature or product datasheets. The correct storage temperature for sterile packaged clone UCHT-4 is 2-8°C (36-46°F). This temperature range must be maintained consistently to preserve the integrity and functionality of the antibody clone. Storage RequirementsThe UCHT-4 clone should be stored under refrigerated conditions with several important considerations: Temperature Control: Maintain strict refrigeration between 2-8°C at all times. This temperature range is critical for preserving the biological activity of the monoclonal antibody. Light Protection: The clone must be protected from prolonged exposure to light during storage to prevent degradation of the fluorescent conjugates. Turbidity Management: If slight turbidity occurs during prolonged storage, the solution can be clarified by centrifugation before use, but this indicates the importance of proper storage conditions. Additional Storage ConsiderationsFor optimal preservation of sterile packaged biological materials like UCHT-4, storage conditions on the premises are particularly important. The actual storage environment, rather than just manufacturer specifications, determines the effective storage duration and product stability. Proper documentation and monitoring of these storage conditions should be maintained as part of standard laboratory hygiene protocols. The 2-8°C storage requirement aligns with standard pharmaceutical refrigerator storage conditions, which falls within the "Refrigerator Storage" category for biological products. Exposure to temperatures outside this range, whether freezing or room temperature, can compromise the antibody's binding capacity and overall performance in immunological assays. Commonly used antibodies or proteins alongside UCHT-4 in the literature are typically those targeting related epitopes or proteins within the same experimental context, such as other monoclonal antibodies targeting regions of interest (e.g., HIV Env, Tau protein, cell markers) or proteins relevant for detection and functional assays. Essential context and details:
Additional notes:
Key Findings from clone UCHT-4 Citations in Scientific LiteratureClone UCHT-4 is a monoclonal antibody clone specific for human CD8, a marker predominantly expressed on cytotoxic T cells and some regulatory T cell subsets. While the provided search results include a product datasheet for anti-CD8-Quantum Red, clone UCHT-4, there is no direct mention of specific scientific findings from primary research publications using this clone in the presented excerpts. However, the datasheet lists several references that are likely to include original research articles where UCHT-4 was employed as a reagent for T cell characterization. Below is a synthesis of expected and indicative findings based on the scientific context and the types of studies typically cited for such reagents. Indicative Research Context for UCHT-4
Typical Findings from Original CitationsAlthough detailed content from the specific citations is not provided in the search results, the references listed in the datasheet are classic papers in immunology and lymphocyte phenotyping. You can reasonably expect the following types of findings from such citations:
Limitations of Available InformationThe search results do not provide direct access to the full texts of the cited papers or detailed summaries of their findings. Therefore, the above points are based on the expected scientific content associated with such a well-established immunological reagent and the context provided by the datasheet. Summary Table
ConclusionClone UCHT-4 is a critical tool in immunology for identifying human CD8+ T cells. While the search results do not detail specific experimental results from the original citations, these papers are foundational in establishing the use of UCHT-4 for phenotyping, functional analysis, and clinical correlation studies of CD8+ T cell populations in health and disease. For precise scientific findings, direct examination of the individual cited works (e.g., Reinherz et al., 1980, 1981; Merkenschlager et al., 1988, 1989; Martin et al., 1984; etc.) would be required. References & Citations1. Parnes, J. R. et al. (1989) Adv. Immunol. 44:265
2. Reinherz, E. L. et al. (1980) J. Immunol. 124:1301
3. Fischer, A. et al. (1983) Immunology 48:177
4. Merkenschlanger, M. et al. (1988) Eur. J. Immunol. 18:1653
5. Leukocyte Typing: 3rd Workshop: Code No. 567; 4th Workshop: Code No. N31 Technical ProtocolsCertificate of Analysis |
Related Products
Prod No. | Description |
---|---|
S211 | |
R1364 | |
I-118 | |
M1188 | |
C247 | |
F1175 | |
S571 |
Formats Available
Prod No. | Description |
---|---|
C2068 | |
C117 | |
C120 | |
C118 | |
C119 | |
C2060 | |
C2061 | |
C2062 | |
C2064 | |
C2066 | |
C366 | |
C312 | |
C666 |
